Combinatorial RNA-based Therapies for HIV-1

Modern Biopharmaceuticals: Design, Development and Optimization

Volumn 2, Issue , 2008, Pages 569-580

  Morris, Kevin V ^a   Rossi, John J ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Combinatorial; Morbidity; Phosphodiester; Ribozymes; Seroconversion

Indexed keywords

EID: 84889964545     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527620982.ch23     Document Type: Chapter

References (86)

1. Idemyor, V. 2003. 20 years since human immunodeficiency virus discovery: considerations for the next decade. Pharmacotherapy 23, 384-387.
2. Ho, D. D., Y. Huang. 2002. The HIV-1 vaccine race. Cell 110, 135-138.
3. D'Aquila, R.T., J.M. Schapiro, et al. 2003. Drug resistance mutations in HIV-1. Topics HIV Med 11 (May-June), 92-96.
4. Maggiolo, F., D. Ripamonti, et al. 2003. Oncea- day HAART: dream or reality? HIV Clin Trials 4, 193-201.
5. Kruger, K., P. J. Grabowski, et al. 1982. Selfsplicing RNA: autoexcision and autocyclization of the ribosomal RNA intervening sequence of Tetrahymena. Cell 31, 147-157.
6. Guerrier-Takada, C., K. Gardiner, et al. 1983. The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 35, 849-857.
7. Cech, T. R. 1990. Self-splicing of group I introns. Annu Rev Biochem 59, 543-568.
8. Marschall, P., J. B. Thomson, et al. 1994. Inhibition of gene expression with ribozymes. Cell Mol Neurobiol 14, 523-538.
9. Amarzguioui, M., H. Prydz. 1998. Hammerhead ribozyme design and application. Cell Mol Life Sci 54, 1175-1202.
10. James, H.A., I. Gibson. 1998. The therapeutic potential of ribozymes. Blood 91, 371-382.
11. Zhou, C., I. C. Bahner, et al. 1994. Inhibition of HIV-1 human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes. Gene 149, 33-39.
12. Yamada, O., M. Yu, et al. 1994. Intracellular immunization of human T cells with a hairpin Ribozyme against HIV-1. Gene Ther 1, 38.
13. Akhtar, S., H. James, et al. 1995. Molecular DIY with hairpins and hammerheads. Nat Med 1, 300-302.
14. Macpherson, J. L., J. A. Ely, et al. 1999. Ribozymes in gene therapy of HIV-1. Front Biosci 4, 497-505.
15. Rossi, J. J. 2000. Ribozyme therapy for HIV infection. Adv Drug Deliv Rev 44, 71-78.
16. Sioud, M., K. Drlica. 1991. Prevention of HIV-1 integrase expression in Escherichia coli by a ribozyme. Proc Natl Acad Sci USA 88, 7303-7307.
17. Dropulic, B., N.H. Lin, et al. 1992. Functional characterization of a U5 ribozyme: intracellular suppression of HIV-1 expression. J Virol 66, 1432-1441.
18. Leavitt, M.C., M. Yu, et al. 1994. Transfer of an anti-HIV-1 ribozyme gene into primary human lymphocytes. Human Gene Ther 5, 1115-1120.
19. Sun, L. Q., L. Wang, et al. 1995. Target sequence- specific inhibition of HIV-1 replication by ribozymes directed to tat RNA. Nucleic Acids Res 23, 2909-2913.
20. Michienzi, A., S. Li, et al. 2002. A nucleolar TAR decoy inhibitor of HIV-1 replication. Proc Natl Acad Sci USA 99, 14047-14052.
21. Tijsterman, M., R. F. Ketting, et al. 2002. The genetics of RNA silencing. Annu Rev Genet 36, 489-519.
22. Montgomery, M.K., S. Xu, et al. 1998. RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans. Proc Natl Acad Sci USA 95, 15502-15507.
23. Nishikura, K. 2001. A short primer on RNAi: RNA-directed RNA polymerase acts as a key catalyst. Cell 107, 415-418.
24. Sharp, P. A. 2001. RNA interference. Genes Dev 15, 485-490.
25. Sui, G., C. Soohoo, et al. 2002. A DNA vectorbased RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci USA 99, 5515-5520.
26. Martinez, J., A. Patkaniowska, et al. 2002. Single- stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 110, 563-574.
27. Sumimoto, H., M. Miyagishi, et al. 2003. Development of an efficient small interfering RNA (siRNA) expression system with a lentiviral vector. Mol Ther 7, S34.
28. Hamada, M., T. Ohtsuka, et al. 2002. Effects on RNA interference in gene expression (RNAi) in cultured mammalian cells of mismatches and the introduction of chemical modifications at the 30162-ends of siRNAs. Antisense Nucleic Acid Drug Dev 12, 301-309.
29. Liu, J., M.A. Carmell, et al. 2004. Argonaute2 is the catalytic engine of mammalian RNAi. Science 305, 1437-1441.
30. Sijen, T., I. Vign, et al. 2001. Transcriptional and posttranscriptional gene silencing are mechanistically related. Curr Biol 11, 436-440.
31. Pal-Bhadra, M., U. Bhadra, et al. 2002. RNAi related mechanisms affect both transcriptional and posttranscriptional transgene silencing in Drosophila. Mol Cell 9, 315-327.
32. Bosher, J. M., P. Dugourcq, et al. 1999. RNA interference can target pre-mRNA: consequences for gene expression in a Caenorhabditis elegans operon. Genetics 153, 1245-1256.
33. Wassenegger, M. 2000. RNA-directed DNA methylation. Plant Mol Biol 43, 203-220.
34. Wassenegger, M., M.W. Graham, et al. 1994. RNA-directed de novo methylation of genomic sequences in plants. Cell 76, 567-576.
35. Zeng, Y., B.R. Cullen. 2002. RNA interference in human cells is restricted to the cytoplasm. RNA 8, 855-860.
36. Fire, A., S. Xu, et al. 1998. Potent and specific genetic interference by double stranded RNA in Caenorhabditis elegans. Nature 391, 806-811.
37. Ngo, H., C. Tschudi, et al. 1998. Doublestranded RNA induces mRNA degradation in Trypanosoma brucei. Proc Natl Acad Sci USA 95, 14687-14692.
38. Volpe, T. A., C. Kidner, et al. 2002. Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science 297, 1833-1837.
39. Kawasaki, H., K. Taira. 2004. Induction of DNA methylation and gene silencing by short interfering RNAs in human cells. Nature 431, 211-217.
40. Morris, K.V., C. Chung, et al. 2004. Inhibition of HIV-1 replication by siRNA targeting conserved regions of gag/pol. RNA Biol 1, 114-117.
41. Kawasaki, H., K. Taira, et al. 2005. siRNA induced transcriptional gene silencing in mammalian cells. Cell Cycle 4(3), in press.
42. Coburn, G.A., B. R. Cullen. 2002. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J Virol 76, 9225-9231.
43. Lee, N. S., T. Dohjima, et al. 2002. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 19, 500-505.
44. Novina, C. D., M.F. Murray, et al. 2002. si-RNA-directed inhibition of HIV-1 infection. Nat Med 8, 681-686.
45. Surabhi, R. M., R. B. Gaynor. 2002. RNA interference directed against viral and cellular targets inhibits human immunodeficiency virus type 1 replication. J Virol 76, 12963-12973.
46. Morris, K.V., J. Gilbert, et al. 2004. Transduction of cell lines and primary cells by FIVpackaged HIV vectors. Mol Ther 10, 181-190.
47. Morris, K.V., S.W. Chan, et al. 2004. Small interfering RNA-induced transcriptional gene silencing in human cells. Science 305, 5688, 1289-1292.
48. Jacque, J., K. Triques, et al. 2002. Modulation of HIV-1 replication by RNA interference. Nature 26, 1-4.
49. Qin, X., D. An, et al. 2002. Inhibiting HIV-1 infection in human T cells by lentiviral mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci USA 100, 183-188.
50. Lee, N. S., J. J. Rossi. 2004. Control of HIV-1 replication by RNA interference. Virus Res 102, 53-58.
51. Llave, C., K.D. Kasschau, et al. 2000. Virus-encoded suppressor of posttranscriptional gene silencing targets a maintenance step in the silencing pathway. Proc Natl Acad Sci USA 97, 13401-13406.
52. Johansen, L. K., J. C. Carrington. 2001. Silencing on the spot. Induction and suppression of RNA silencing in the Agrobacterium-mediated transient expression system. Plant Physiol 126, 930-938.
53. Mallory, A. C., L. Ely, et al. 2001. HC-Pro suppression of transgene silencing eliminates the small RNAs but not transgene methylation or the mobile signal. Plant Cell 13, 571-583.
54. Hamilton, A., O. Voinnet, et al. 2002. Two classes of short interfering RNA in RNA silencing. EMBO J 21, 4671-4679.
55. Li, H., W. X. Li, et al. 2002. Induction and suppression of RNA silencing by an animal virus. Science 296, 1319-1321.
56. Mallory, A. C., B. J. Reinhart, et al. 2002. A viral suppressor of RNA silencing differentially regulates the accumulation of short interfering RNAs and micro-RNAs in tobacco. Proc Natl Acad Sci USA 99, 15228-15233.
57. Gitlin, L., S. Karelsky, et al. 2002. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 26, 1-5.
58. Westerhout, E. M., M. Ooms, et al. 2005. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res 33, 796-804.
59. Nahreini, P., A. J. Hanson, et al. 2004. Altering cellular signaling pathways enhance gene silencing activity of shRNA, shRNA, ribozyme, and shRNA antisense in neuroblastoma cells. Cell Mol Neurobiol 24, 781-792.
60. Sioud, M., D.R. Sorensen. 2003. Cationic liposome- mediated delivery of siRNAs in adult mice. Biochem Biophys Res Commun 312, 1220-1225.
61. Soutschek, J., A. Akinc, et al. 2004. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432, 7014, 173-178.
62. Morris, M.C., P. Vidal, et al. 1997. A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res 25, 2730-2736.
63. Ritter, W., C. Plank, et al. 2003. A novel transfecting peptide comprising a tetrameric nuclear localization sequence. J Mol Med 81, 708-717.
64. Sledz, C. A., M. Holko, et al. 2003. Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 5, 834-839.
65. Pebernard, S., R. D. Iggo. 2004. Determinants of interferon-stimulated gene induction by RNAi vectors. Differentiation 72, 103-111.
66. Persengiev, S. P., X. Zhu, et al. 2004. Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10, 12-18.
67. Wu, X., Y. Li, B. Crise, et al. 2003. Transcription start regions in the human genome are favored targets for MLV integration. Science 300, 1749-1751.
68. Buchschacher, G. L., F. Wong-Staal. 2000. Development of lentiviral vectors for gene therapy for human diseases. Blood 95, 2499-2504.
69. Greber, U. F., A. Fassati. 2003. Nuclear import of viral DNA genomes. Traffic 4, 136-143.
70. Duzgunes, N., S. Simoes, et al. 2001. Delivery of novel macromolecular drugs against HIV-1. Expert Opin Biol Ther 6, 949-970.
71. Gervaix, A., L. Schwarz, et al. 1997. Gene therapy targeting peripheral blood CD34+ hematopoietic stem cells of HIV-infected individuals. Hum Gene Ther 8, 2229-2238.
72. Yam, P.Y., S. Li, et al. 2002. Design of HIV vectors for efficient gene delivery into human hematopoietic cells. Mol Ther 5, 479-484.
73. Poeschla, E., P. Corbeau, et al. 1996. Development of HIV vectors for anti-HIV gene therapy. Proc Natl Acad Sci USA 93, 11395-11399.
74. Price, M.A., S. S. Case, et al. 2002. Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cells. Mol Ther 6, 645-652.
75. Quinonez, R., R. E. Sutton. 2002. Lentiviral vectors for gene delivery into cells. DNA Cell Biol 12, 937-951.
76. White, S. M., et al. 1999. Lentivirus vectors using human and simian immunodeficiency virus elements. J Virol 73, 2832-2840.
77. Browning, M.T., R.D. Schmidt, et al. 2001. Primate and feline lentivirus vector RNA packaging and propagation by heterologous lentivirus virions. J Virol 75, 5129-5140.
78. Goujon, C., L. Jarrosson-Wuilleme, et al. 2003. Heterologous human immunodeficiency virus type 1 lentiviral vectors packaging a simian immunodeficiency virus-derived genome display a specific postentry transduction defect in dendritic cells. J Virol 787, 9295-9304.
79. Kobinger, G. P., D. J. Weiner, et al. 2001. Filovirus- pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat Biotechnol 19, 225-230.
80. Sandrin, V., Russell, S. J., et al. 2003. Targeting retroviral and lentiviral vectors. Curr Topics Microbiol Immunol 281, 137-178.
81. Boerger, A. L., S. Snitkovsky, et al. 1999. Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types. Proc Natl Acad Sci USA 96, 9867-9872.
82. Pasquinelli, A. E. 2002. MicroRNAs: deviants no longer. Trends Genet 18, 171-173.
83. Michienzi, A., S. Prislei, et al. 1996. U1 small nuclear RNA chimeric ribozymes with substrate specificity for Rev pre-mRNA of HIV. Proc Natl Acad Sci USA 93, 7219-7224.
84. Wolkowicz, R., G.P. Nolan, et al. 2004. Lentiviral vectors for the delivery of DNA into mammalian cells. Methods Mol Biol 246, 391-411.
85. Lee, Y., C. Ahn, et al. 2003. The nuclear RNase III Drosha initiates microRNA processing. Nature 425, 415-419.
86. Lund, E., S. Guttinger, et al. 2004. Nuclear export of microRNA precursors. Science 303, 95-98.